Real-world evidence of febrile neutropenia-related hospitalization on patients with perioperative chemotherapy for early breast cancer in Japan
This nationwide real-world data analysis revealed the incidence, duration, treatment patterns, and medical cost of FNH in patients with EBC receiving perioperative chemotherapy in Japan. These findings indicate that FNH imposes a considerable burden on patients' daily lives, including time and financial impacts, contributing to the implementation of appropriate shared decision-making for primary G-CSF prophylaxis.
Authors
- Nobuhiro Shibata (ORCID: https://orcid.org/0000-0001-8647-5098)
- Tomoyuki Nukada
- Shinji Ohno (ORCID: https://orcid.org/0000-0003-2093-3353)
- Tetsuhiro Yoshinami (ORCID: https://orcid.org/0009-0000-8747-3641)
- Kazuhiro Ishimaru (ORCID: https://orcid.org/0000-0003-4867-8841)
- Satoru Ito (ORCID: https://orcid.org/0000-0001-6531-4172)
- Kentaro Tamaki
Institutions
- Kansai Medical University (JP)
- Okinawa University (JP)
- Kyowa Kirin (Japan) (JP)
- Kagoshima City Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Breast Cancer
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1007/s12282-025-01714-6
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00